Products

What will AGI do for Biphenamine or xenysalate?

This classification denotes an astringent with the molecular formula C19H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 65X88IL51X, chemically known as (1,1-biphenyl)-3-carboxylic acid, 2-hydroxy-, 2-(diethylamino)ethyl ester but generally known as biphenamine, which bears US NIH Compound Identifier 21720. Biphenamine most often comes in base, hydrochloride, and q forms. European Medicines Agency schedules Xenysalate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00108MIG. The term XENYSALATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules biphenamine in its Anatomical Therapeutic Chemical (ATC) Classification. Biphenamine or xenysalate bears US NLM identifiers UMLS ID C0302226 and NCI Concept Code C79881. SMILES: CCN(CC)CCOC(=O)C1=CC=CC(=C1O)C2=CC=CC=C2.

How AGI delivers it

Four ways AGI delivers for Biphenamine or xenysalate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Biphenamine or xenysalate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Biphenamine or xenysalate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Biphenamine or xenysalate connects

measured by

  • Assay Contentmodel
  • Compound Puritymodel
  • Melting Pointmodel
  • Microbial Limitmodel